Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma

30 Aug 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cutaneous Melanoma Detection and Management
Share to Melanoma and MAPK Pathways
Share to vaccines and immunoinformatics approaches

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22931913
DOI: 10.1038/jid.2012.283

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III MelanomaPMID 22931913Read ↗

Dissection of Immune Gene Networks in Primary Melanoma Tumors Critical for Antitumor Surveillance of Patients with Stage II–III Resectable DiseaseSemantic proximity Read ↗

Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.Semantic proximity Read ↗

The immune-related role of BRAF in melanoma.Semantic proximity Read ↗

Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patientsSemantic proximity Read ↗

Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanomaSemantic proximity Read ↗

Gene expression profiling-based identification of molecular subtypes in stage IV melanomas with different clinical outcome.Semantic proximity Read ↗

PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma.Semantic proximity Read ↗

NOTCH4 mutation as predictive biomarker for immunotherapy benefits in NRAS wildtype melanoma.Semantic proximity Read ↗

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.Semantic proximity Read ↗

Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic MelanomaSemantic proximity Read ↗

Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?Semantic proximity Read ↗

Gene expression signature associated with BRAF mutations in human primary cutaneous melanomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.